DIGEMID leads the Peruvian Pharmacovigilance and Technovigilance System through the National Centre for Pharmacovigilance and Technovigilance (CENAFyT).
Core official resources
- Pharmacovigilance and technovigilance — national system, legal basis and operational materials.
- Electronic adverse-event notification — NotiMED for medicines and NotiVAC for vaccines.
Practical use
The DIGEMID hub is the starting point for national requirements and safety material. NotiMED and NotiVAC are the current public electronic notification routes described by DIGEMID for suspected medicine adverse reactions and vaccine-related events.